European Spinouts Report 2026
by AlbionVC, Atlantic, FORWARD.one, MiTO Technologies and Dealroom
European Deep Tech and Life Sciences spinouts approach $500 billion in value as funding hits a record high
Deep tech and life sciences startups that have spun out of Europe’s universities and research centres are now worth a combined $492 billion, having created over 220,000 jobs across more than 9,300 startups. Investment into these companies has also reached its highest level ever, with $13.8 billion raised so far in 2026 and $16.1 billion projected by year-end.
The European Spinouts Report 2026 analyses European value creation and trends in spinouts, highlighting the region’s leading academic institutions, countries, sectors, and founders. Now in its second edition, the report is produced by Dealroom.co together with us at AlbionVC, Atlantic, MITO Technology, Forward.one, and launched exclusively at Slush in Helsinki.
The University of Oxford tops this year’s European University Spinout Ranking, followed by the University of Cambridge, ETH Zurich and École Polytechnique Fédérale de Lausanne (EPFL), with the Technical University of Munich (TU Munich) completing the top five. UK institutions hold five places in the top ten, with UCL, Imperial College London and the University of Bristol joining Oxford and Cambridge. CNRS tops the research centres ranking, followed by the Max Planck Society, CEA, INSERM and the Helmholtz Association. Beyond France and Germany, VTT (Finland), VIB (Belgium) and TNO (Netherlands) complete the top ten.
At the country level, the UK leads for spinout value creation, followed by Germany, France and Switzerland. Adjusted for population, Switzerland is the clear leader, followed by Finland, Sweden, Denmark, the UK, Belgium and the Netherlands.
The report’s key findings include:
- Deep tech and life sciences spinouts from European universities and research centres are worth $492 billion and have created over 220,000 jobs across more than 9,300 startups. The number of people they employ has grown 2.8x since 2020.
- Value creation is accelerating, with 49% of all spinout value coming from companies founded since 2015.
- 100spinouts have reached $100M+ revenues and/or a $1B+ valuation. 14 spinouts reached unicorn status or $1B+ exits so far this year, on track for the highest ever excluding 2021.
- European deep tech and life sciences spinouts have raised $13.8 billion so far in 2026 and are on track to reach $16.1 billion by year-end, a 44% increase on 2025’s previous all-time high. The largest rounds this year have focused on space and defence, semiconductors and quantum, nuclear fusion and life sciences.
- Exit activity by value is at historical highs when excluding 2021, with $14.8 billion so far in 2026, and public listings are making a comeback after nearly five years dominated solely by M&A. So far in 2026, Europe has seen eight $1B+ exits: six from spinouts headquartered in Europe, including the SPAC listings of quantum spinouts Pasqal (Paris-Saclay University) and IQM (Aalto University & VTT), and two from US spinouts from European university and research centers.
- US acquirers have captured the majority of European spinout exit value, over $33 billion since 2020. Acquisitions by European players made up the majority of deals by count and around one quarter of total value, while Asia, especially Japan, is also a strong exit route.
- At the early stage, 89% of capital comes from within Europe, backed by a strong scene of university venture funds, independent spinout specialists and other deep tech and life sciences investors. However, 44% of late-stage funding still comes from outside Europe, mainly from the US. This dependency is easing: the European share of late-stage funding has risen to 56% in 2025-2026, up from 46% in 2018-2020 and 35% in 2021-2022.
- Spinouts have become a larger part of the wider technology ecosystem, accounting for 46% of new deep tech and life sciences startups since 2019, 85% more than in 2010-2018, and an even larger share of scaleups and enterprise value created.
- Compared to the US since 1990, Europe has slightly more VC-backed spinouts, but is 2–3x behind on unicorns and funding, and 13x on value created, driven by a few US outliers. Looking only at spinouts launched since 2010, the value gap narrows to 3x. Europe needs to convert more of its spinouts into large-scale outcomes.
- Deep tech has now overtaken life sciences on most metrics, with a much wider early-stage pipeline and more scaleups and VC funding, while life sciences still narrowly leads on unicorns and enterprise value. Around two-thirds of quantum and photonics startups (68%) and 59% of medical devices startups are research spinouts, compared with 29% in robotics, 26% in defence and 25% in space. Even so, space and defence spinouts have created strong value and are showing strong momentum in funding rounds and exits.
- Leadership varies by sector: the University of Oxford ranks first for semiconductor and life sciences spinouts, ETH Zurich for robotics. TU Munich leads in AI x deep tech and space, EPFL in medical devices, and Bundeswehr University Munich in defence.
A positive loop on spinout terms and IP
In last year’s report, the authors called for more standardisation and transparency in spinout terms. Twelve months on, a positive loop is in motion, with countries learning from one another and converging on best practices for equity, royalties, licensing and speed:
- UK: The Independent Review of University Spinouts (2023), building on the TenU USIT guide, set voluntary guidelines that more than 69 universities have now committed to. The impact is already visible: the average university equity stake in UK spinouts fell from 25% in 2023 to 16% in 2025, the lowest level in a decade, according to Dealroom’s analysis of Companies House filings for the Royal Academy of Engineering’s Spotlight on Spinouts 2026.
- Denmark: Since January 2026, all major Danish universities use joint standard contracts, the most comprehensive standard legal terms in Europe, after a political agreement made innovation and startup creation a core statutory purpose of universities. The model is royalty-first, with 1–6% royalties depending on sector, no upfront fees, a pre-agreed right to buy the IP, and an optional mixed model with a 3–5% equity stake that is non-dilutive until €2.7M has been raised.
- Germany: The German Spin-Off Framework (GSOF), published in June 2026 and co-created by 44 stakeholders from research, technology transfer, venture capital and law, defines voluntary “landing zones”: 5–15% equity for deep tech, 1–5% royalties, founders keeping at least 85% at formation, upfront fees discouraged, and negotiations concluded within eight weeks. The framework now needs to make the first steps towards implementation.
- Netherlands: Dutch universities updated their National IP Deal Term Principles in November 2025, and in June 2026 TechChampions proposed complementary “Express Terms”: a fast-track route inspired by ETH Zurich, with 2–4% university equity protected against dilution up to a cap, and royalties of 0.5–2%.
The authors of the report have shared the following recommendations for European universities, technology transfer offices and policymakers to improve the spinout process:
- Establish standardised spinout terms: Spinout terms still vary widely across universities, countries and individual deals, and guidelines are often opaque. Progress is under way, with countries learning from each other. Since the UK’s 2023 Independent Review, the average university equity stake in UK spinouts has fallen from 25% to 16%. This year all major Danish universities adopted a new legal template, Germany published a national spinout framework, the Netherlands proposed new Express Terms, and an EU Blueprint is due by the end of 2026. Not every framework covers all the key deal terms, though. Beyond equity, royalties, exit fees and board seats matter too, and the time it takes to spin out should be an explicit target.
- Reform success metrics: Most spinout reporting in Europe still counts only the number of spinouts, which can create the wrong incentives. Success should be measured by value creation instead. That means the number of spinouts reaching key milestones (VC-backed; scaleup with $15M+ funding, 50+ employees and/or a $100M+ valuation; unicorns, $1B+ exits and $100M+ revenues), combined enterprise value and total funding raised, alongside jobs created and revenue generated.
- Support spinout growth at both ends: Late-stage funding remains limited: 44% of funding in $100M+ rounds for European spinouts still comes from outside Europe. That is down from 65% in 2021–2022, and initiatives such as the Scaleup Europe Fund, France’s Tibi initiative and the UK’s Mansion House Accord are helping to close the gap. At the earliest stage, proof-of-concept (PoC) funding is key to crossing the first “Valley of Death”, but funding available to universities is limited. More PoC funding for universities could significantly boost spinout creation in Europe.
- Foster mindset change and incentives: Entrepreneurship is increasingly recognised as a third pillar of academia alongside teaching and research, but many researchers in Europe still don’t see it as a career option alongside a publication-focused path. Career progression rarely rewards an entrepreneurial mindset. Universities have a range of financial and non-financial incentives to change this, and early signs of change are starting to show.
Yoram Wijngaarde, Founder & CEO, Dealroom.co: “A year ago, this report measured for the first time how much value Europe’s universities create through spinouts. This year the numbers speak even louder: European spinouts are approaching half a trillion dollars in value, attracting record funding and producing category-leading companies and outcomes. Europe’s universities are one of the continent’s most important engines of company creation. The challenge now is making sure these companies can scale here, with more late-stage capital, and rapid, standardised spinout terms that reward real value creation.”
Christophe Maire, Founder & Managing Partner, Atlantic: “Spinouts are the new publication. Building companies, solving real problems and serving customers with the ambition to become global leaders now beats publishing in academic journals. Europe’s scientific depth has always been world-class; what has improved dramatically is the determination of founders to commercialise it, and an ecosystem increasingly ready to support them. This year’s data shows this clearly: a growing number of researchers are turning scientific breakthroughs into some of Europe’s most valuable companies. At Atlantic, we’re first believers in scientific entrepreneurs venturing into the unknown”
Prof. Massimiliano Granieri, Managing Director, MITO Technology: “Every spinout is proof that European science can build new markets. Spinouts are one of Europe’s most powerful engines for turning science into new industries. With 14 new unicorns and $1B+ exits from European spinouts in 2026 alone, the case is made: research turned into companies creates sustainable and lasting value. Universities and public research institutions should treat spinout creation and growth as a core metric, one that attracts the best students, talent and funding as much as publications and a perspective of academic career do. The way forward is simple: lighter procedures, faster company formation and standard IP terms that put founders in the driving seat. Then spinouts can do what Europe needs most: connect with our industrial know-how and, above all, open value chains and markets that do not exist yet. At MITO Technology, we back the scientist founders who have the vision and make this happen.”
David Grimm, Partner, AlbionVC: “Having spent over a decade backing university spinouts, it’s encouraging to see a record year for value creation in Europe, with three decacorns and eight $1bn+ exits. Europe has world-class technical talent, an increasingly strong early-stage investment ecosystem and a growing number of ambitious academics turned founders building companies around frontier technologies. The challenge is getting these businesses out of universities faster, then ensuring they have access to the deep pools of capital needed to support $100m+ rounds and build the next generation of global technology leaders in Europe.”
Riemer Smink, General Partner, Forward.one: “The next category-defining companies are being built in Europe’s labs. Our job is to make sure they grow here. Breakthrough technology rarely comes from improving what already exists. It comes from research that opens up something entirely new, and much of that research happens in Europe’s universities. At FORWARD.one, we invest early, and we believe spinouts should reach customers early too, because a market teaches a company more than another grant cycle can. Universities and investors should make spinning out simpler, with fair IP terms and founders in the driving seat. Companies built on European science should scale here and, when the time comes, be acquired here. Building in Europe, for Europe, isn’t a slogan. It’s how we keep the value of our science.”
Noora Saksa, CEO, Slush: “Europe has a research commercialization gap: Scientific breakthroughs are sitting in labs, when they could be applied in real life and solving the world’s most complex problems. Spinouts are the way to do this. This is exactly why Slush has launched its flagship Spinout track, dedicated to making the leap from research to startup feel more attainable and help turn discoveries into companies.”
Having spent over a decade backing university spinouts, it’s encouraging to see a record year for value creation in Europe, with three decacorns and eight $1bn+ exits. Europe has world-class technical talent, an increasingly strong early-stage investment ecosystem and a growing number of ambitious academics turned founders building companies around frontier technologies. The challenge is getting these businesses out of universities faster, then ensuring they have access to the deep pools of capital needed to support $100m+ rounds and build the next generation of global technology leaders in Europe.
David Grimm, Partner AlbionVC